CareRx Corporation Stock: price and insider trades · Canada
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 3,500 shares@ CA$3.350.0055% mcap0.7% of flowCommon SharesTSXSEDI:4796622
- 3,500 shares@ CA$3.330.0055% mcap0.7% of flowCommon SharesTSXSEDI:4796621
- 3,500 shares@ CA$3.350.0055% mcap0.7% of flowCommon SharesTSXSEDI:4796620
- 3,500 shares@ CA$3.320.0054% mcap0.6% of flowCommon SharesTSXSEDI:4796617
- 3,500 shares@ CA$3.34Common SharesTSXSEDI:4796616
- 2,100 shares@ CA$3.35Common SharesTSXSEDI:4796615
- 3,100 shares@ CA$3.34Common SharesTSXSEDI:4796614
- 1,400 shares@ CA$3.30Common SharesTSXSEDI:4796612
- 2,600 shares@ CA$3.27Common SharesTSXSEDI:4796611
- 3,200 shares@ CA$3.29Common SharesTSXSEDI:4796610
- 3,500 shares@ CA$3.25Common SharesTSXSEDI:4796609
- 3,200 shares@ CA$3.29Common SharesTSXSEDI:4796607
- 2,800 shares@ CA$3.36Common SharesTSXSEDI:4796606
- 3,500 shares@ CA$3.34Common SharesTSXSEDI:4796605
- 1,100 shares@ CA$3.30Common SharesTSXSEDI:4796604
- 1,200 shares@ CA$3.29Common SharesTSXSEDI:4796603
- 3,500 shares@ CA$3.25Common SharesTSXSEDI:4796602
- 2,900 shares@ CA$3.25Common SharesTSXSEDI:4796601
- 50,900 shares@ CA$3.20Common SharesTSXSEDI:4796600
- 3,500 shares@ CA$3.27Common SharesTSXSEDI:4796599
- 149,000 sharesCommon SharesTSXSEDI:4796598
- 3,100 shares@ CA$3.26Common SharesTSXSEDI:4796597
- 516 shares@ CA$3.2152.9% of flowRestricted Stock UnitsTSXSEDI:4790614
- 849 shares@ CA$3.2152.9% of flowRestricted Stock UnitsTSXSEDI:4790608
- 49 shares@ CA$3.210.0001% mcap0.2% of flowDeferred Share UnitsTSXSEDI:4790606
25 of 322 declarations
About CareRx Corporation
CareRx Corporation, a Canadian health care company listed on the Toronto Stock Exchange, published 157 of its 239 filings in 2026, and the company itself, filed as issuer, signs 69. Market trades there are small: 8 purchases worth EUR 39,033 (median EUR 2,490) and 15 sales worth EUR 121,737 (median EUR 4,549), or 35% purchases. The record is mostly 92 option exercises, 48 grants and 76 filings of another kind.
Kevin Dalton, a director, is the top individual filer, with 45 filings, 7 of them purchases and 13 sales. Kevin Dalton sold EUR 41,015 on September 17, 2025 and EUR 9,405 on June 16, 2025, and bought EUR 5,360 on August 10, 2026 and EUR 4,106 on August 12, 2026. Jeff Watson, a director, bought EUR 19,496 on May 8, 2025, the largest purchase in the record, and sold EUR 16,096 on September 18, 2025.
Read moreShow less
The last twelve months hold 189 filings, including 7 purchases and 5 sales. Filings appear with a 6-day delay as a median. The 14 filers hold 10.5% of the capital, valued at CAD 209.3 million.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
